nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrochlorothiazide—KCNMA1—prostate gland—urinary bladder cancer	0.0118	0.0607	CbGeAlD
Hydrochlorothiazide—SLC12A3—renal system—urinary bladder cancer	0.0116	0.0599	CbGeAlD
Hydrochlorothiazide—CA5B—prostate gland—urinary bladder cancer	0.0102	0.0522	CbGeAlD
Hydrochlorothiazide—SLC12A3—female reproductive system—urinary bladder cancer	0.00932	0.0479	CbGeAlD
Hydrochlorothiazide—KCNMA1—epithelium—urinary bladder cancer	0.00868	0.0446	CbGeAlD
Hydrochlorothiazide—KCNMA1—smooth muscle tissue—urinary bladder cancer	0.00836	0.043	CbGeAlD
Hydrochlorothiazide—CA9—female reproductive system—urinary bladder cancer	0.00836	0.043	CbGeAlD
Hydrochlorothiazide—KCNMA1—renal system—urinary bladder cancer	0.00805	0.0414	CbGeAlD
Hydrochlorothiazide—CA12—renal system—urinary bladder cancer	0.00772	0.0397	CbGeAlD
Hydrochlorothiazide—CA4—prostate gland—urinary bladder cancer	0.00701	0.0361	CbGeAlD
Hydrochlorothiazide—CA5B—urethra—urinary bladder cancer	0.0068	0.035	CbGeAlD
Hydrochlorothiazide—KCNMA1—female reproductive system—urinary bladder cancer	0.00645	0.0332	CbGeAlD
Hydrochlorothiazide—CA12—female reproductive system—urinary bladder cancer	0.00618	0.0318	CbGeAlD
Hydrochlorothiazide—CA1—renal system—urinary bladder cancer	0.00612	0.0314	CbGeAlD
Hydrochlorothiazide—CA4—seminal vesicle—urinary bladder cancer	0.00593	0.0305	CbGeAlD
Hydrochlorothiazide—CA2—prostate gland—urinary bladder cancer	0.00582	0.0299	CbGeAlD
Hydrochlorothiazide—CA5B—female reproductive system—urinary bladder cancer	0.00555	0.0285	CbGeAlD
Hydrochlorothiazide—CA5B—vagina—urinary bladder cancer	0.00502	0.0258	CbGeAlD
Hydrochlorothiazide—CA2—seminal vesicle—urinary bladder cancer	0.00492	0.0253	CbGeAlD
Hydrochlorothiazide—CA1—female reproductive system—urinary bladder cancer	0.0049	0.0252	CbGeAlD
Hydrochlorothiazide—CA4—renal system—urinary bladder cancer	0.00478	0.0246	CbGeAlD
Hydrochlorothiazide—CA4—urethra—urinary bladder cancer	0.0047	0.0241	CbGeAlD
Hydrochlorothiazide—CA2—epithelium—urinary bladder cancer	0.00427	0.022	CbGeAlD
Hydrochlorothiazide—CA2—smooth muscle tissue—urinary bladder cancer	0.00412	0.0212	CbGeAlD
Hydrochlorothiazide—CA9—Cellular response to hypoxia—VHL—urinary bladder cancer	0.00409	0.0719	CbGpPWpGaD
Hydrochlorothiazide—CA2—renal system—urinary bladder cancer	0.00396	0.0204	CbGeAlD
Hydrochlorothiazide—CA4—female reproductive system—urinary bladder cancer	0.00383	0.0197	CbGeAlD
Hydrochlorothiazide—KCNMA1—lymph node—urinary bladder cancer	0.00377	0.0194	CbGeAlD
Hydrochlorothiazide—CA5B—lymph node—urinary bladder cancer	0.00324	0.0167	CbGeAlD
Hydrochlorothiazide—CA2—female reproductive system—urinary bladder cancer	0.00317	0.0163	CbGeAlD
Hydrochlorothiazide—CA2—vagina—urinary bladder cancer	0.00287	0.0148	CbGeAlD
Hydrochlorothiazide—CA1—lymph node—urinary bladder cancer	0.00287	0.0147	CbGeAlD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—PTCRA—urinary bladder cancer	0.00244	0.0429	CbGpPWpGaD
Hydrochlorothiazide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—CREBBP—urinary bladder cancer	0.00239	0.0419	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular response to hypoxia—RBX1—urinary bladder cancer	0.00235	0.0413	CbGpPWpGaD
Hydrochlorothiazide—CA4—lymph node—urinary bladder cancer	0.00224	0.0115	CbGeAlD
Hydrochlorothiazide—CA2—lymph node—urinary bladder cancer	0.00186	0.00955	CbGeAlD
Hydrochlorothiazide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—EP300—urinary bladder cancer	0.00163	0.0286	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00125	0.0219	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—KMT2A—urinary bladder cancer	0.00123	0.0217	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—BIRC3—urinary bladder cancer	0.00123	0.0217	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.00115	0.0202	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—MPO—urinary bladder cancer	0.00106	0.0186	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular response to hypoxia—CREBBP—urinary bladder cancer	0.00105	0.0185	CbGpPWpGaD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—TFRC—urinary bladder cancer	0.00104	0.0182	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular response to hypoxia—EP300—urinary bladder cancer	0.000718	0.0126	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—GSTM1—urinary bladder cancer	0.000661	0.0116	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—NCOR1—urinary bladder cancer	0.000661	0.0116	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000634	0.0111	CbGpPWpGaD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	0.000621	0.0109	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—VHL—urinary bladder cancer	0.000621	0.0109	CbGpPWpGaD
Hydrochlorothiazide—Hepatitis—Methotrexate—urinary bladder cancer	0.000541	0.000723	CcSEcCtD
Hydrochlorothiazide—Sweating—Epirubicin—urinary bladder cancer	0.000541	0.000722	CcSEcCtD
Hydrochlorothiazide—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000541	0.000722	CcSEcCtD
Hydrochlorothiazide—Asthenia—Gemcitabine—urinary bladder cancer	0.000539	0.00072	CcSEcCtD
Hydrochlorothiazide—Haematuria—Epirubicin—urinary bladder cancer	0.000538	0.000718	CcSEcCtD
Hydrochlorothiazide—Pharyngitis—Methotrexate—urinary bladder cancer	0.000537	0.000717	CcSEcCtD
Hydrochlorothiazide—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000534	0.000714	CcSEcCtD
Hydrochlorothiazide—Weight increased—Doxorubicin—urinary bladder cancer	0.000533	0.000711	CcSEcCtD
Hydrochlorothiazide—Epistaxis—Epirubicin—urinary bladder cancer	0.000532	0.000711	CcSEcCtD
Hydrochlorothiazide—Pruritus—Gemcitabine—urinary bladder cancer	0.000532	0.00071	CcSEcCtD
Hydrochlorothiazide—Nausea—Thiotepa—urinary bladder cancer	0.000531	0.000709	CcSEcCtD
Hydrochlorothiazide—Sinusitis—Epirubicin—urinary bladder cancer	0.000529	0.000707	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Etoposide—urinary bladder cancer	0.000529	0.000706	CcSEcCtD
Hydrochlorothiazide—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000528	0.000705	CcSEcCtD
Hydrochlorothiazide—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000526	0.000703	CcSEcCtD
Hydrochlorothiazide—Pneumonia—Doxorubicin—urinary bladder cancer	0.000525	0.000701	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000525	0.000701	CcSEcCtD
Hydrochlorothiazide—Pruritus—Fluorouracil—urinary bladder cancer	0.000523	0.000698	CcSEcCtD
Hydrochlorothiazide—SLC22A6—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000521	0.00916	CbGpPWpGaD
Hydrochlorothiazide—Visual impairment—Methotrexate—urinary bladder cancer	0.000521	0.000696	CcSEcCtD
Hydrochlorothiazide—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000517	0.000691	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000516	0.000689	CcSEcCtD
Hydrochlorothiazide—Bradycardia—Epirubicin—urinary bladder cancer	0.000515	0.000688	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000514	0.000687	CcSEcCtD
Hydrochlorothiazide—Renal failure—Doxorubicin—urinary bladder cancer	0.000513	0.000685	CcSEcCtD
Hydrochlorothiazide—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000511	0.000683	CcSEcCtD
Hydrochlorothiazide—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000511	0.000683	CcSEcCtD
Hydrochlorothiazide—Urticaria—Etoposide—urinary bladder cancer	0.00051	0.000681	CcSEcCtD
Hydrochlorothiazide—Jaundice—Doxorubicin—urinary bladder cancer	0.000509	0.000679	CcSEcCtD
Hydrochlorothiazide—Rhinitis—Epirubicin—urinary bladder cancer	0.000507	0.000678	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Etoposide—urinary bladder cancer	0.000507	0.000678	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Etoposide—urinary bladder cancer	0.000507	0.000678	CcSEcCtD
Hydrochlorothiazide—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000507	0.000677	CcSEcCtD
Hydrochlorothiazide—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000507	0.000677	CcSEcCtD
Hydrochlorothiazide—Hepatitis—Epirubicin—urinary bladder cancer	0.000506	0.000676	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000505	0.000675	CcSEcCtD
Hydrochlorothiazide—Tinnitus—Methotrexate—urinary bladder cancer	0.000504	0.000674	CcSEcCtD
Hydrochlorothiazide—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000504	0.000673	CcSEcCtD
Hydrochlorothiazide—Asthenia—Cisplatin—urinary bladder cancer	0.000502	0.000671	CcSEcCtD
Hydrochlorothiazide—Pharyngitis—Epirubicin—urinary bladder cancer	0.000502	0.000671	CcSEcCtD
Hydrochlorothiazide—Sweating—Doxorubicin—urinary bladder cancer	0.0005	0.000668	CcSEcCtD
Hydrochlorothiazide—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000499	0.000666	CcSEcCtD
Hydrochlorothiazide—Haematuria—Doxorubicin—urinary bladder cancer	0.000497	0.000665	CcSEcCtD
Hydrochlorothiazide—Epistaxis—Doxorubicin—urinary bladder cancer	0.000492	0.000657	CcSEcCtD
Hydrochlorothiazide—Sinusitis—Doxorubicin—urinary bladder cancer	0.000489	0.000654	CcSEcCtD
Hydrochlorothiazide—Dizziness—Fluorouracil—urinary bladder cancer	0.000489	0.000653	CcSEcCtD
Hydrochlorothiazide—Visual impairment—Epirubicin—urinary bladder cancer	0.000488	0.000652	CcSEcCtD
Hydrochlorothiazide—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000487	0.00065	CcSEcCtD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	0.000485	0.00852	CbGpPWpGaD
Hydrochlorothiazide—Diarrhoea—Cisplatin—urinary bladder cancer	0.000479	0.00064	CcSEcCtD
Hydrochlorothiazide—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000479	0.000639	CcSEcCtD
Hydrochlorothiazide—Alopecia—Methotrexate—urinary bladder cancer	0.000478	0.000639	CcSEcCtD
Hydrochlorothiazide—Vomiting—Gemcitabine—urinary bladder cancer	0.000478	0.000638	CcSEcCtD
Hydrochlorothiazide—Bradycardia—Doxorubicin—urinary bladder cancer	0.000477	0.000637	CcSEcCtD
Hydrochlorothiazide—Rash—Gemcitabine—urinary bladder cancer	0.000474	0.000633	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Gemcitabine—urinary bladder cancer	0.000473	0.000632	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Etoposide—urinary bladder cancer	0.000473	0.000631	CcSEcCtD
Hydrochlorothiazide—Tinnitus—Epirubicin—urinary bladder cancer	0.000472	0.00063	CcSEcCtD
Hydrochlorothiazide—Erythema—Methotrexate—urinary bladder cancer	0.000471	0.000629	CcSEcCtD
Hydrochlorothiazide—Headache—Gemcitabine—urinary bladder cancer	0.000471	0.000629	CcSEcCtD
Hydrochlorothiazide—Flushing—Epirubicin—urinary bladder cancer	0.00047	0.000628	CcSEcCtD
Hydrochlorothiazide—Vomiting—Fluorouracil—urinary bladder cancer	0.00047	0.000627	CcSEcCtD
Hydrochlorothiazide—Rhinitis—Doxorubicin—urinary bladder cancer	0.00047	0.000627	CcSEcCtD
Hydrochlorothiazide—Hepatitis—Doxorubicin—urinary bladder cancer	0.000468	0.000626	CcSEcCtD
Hydrochlorothiazide—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000466	0.000623	CcSEcCtD
Hydrochlorothiazide—Rash—Fluorouracil—urinary bladder cancer	0.000466	0.000622	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Fluorouracil—urinary bladder cancer	0.000465	0.000622	CcSEcCtD
Hydrochlorothiazide—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000465	0.000621	CcSEcCtD
Hydrochlorothiazide—Headache—Fluorouracil—urinary bladder cancer	0.000463	0.000618	CcSEcCtD
Hydrochlorothiazide—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000461	0.000616	CcSEcCtD
Hydrochlorothiazide—Dysgeusia—Methotrexate—urinary bladder cancer	0.000461	0.000616	CcSEcCtD
Hydrochlorothiazide—Asthenia—Etoposide—urinary bladder cancer	0.00046	0.000615	CcSEcCtD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000458	0.00805	CbGpPWpGaD
Hydrochlorothiazide—Back pain—Methotrexate—urinary bladder cancer	0.000455	0.000608	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—CREBBP—urinary bladder cancer	0.000455	0.00799	CbGpPWpGaD
Hydrochlorothiazide—Pruritus—Etoposide—urinary bladder cancer	0.000454	0.000606	CcSEcCtD
Hydrochlorothiazide—Arrhythmia—Epirubicin—urinary bladder cancer	0.000452	0.000604	CcSEcCtD
Hydrochlorothiazide—Visual impairment—Doxorubicin—urinary bladder cancer	0.000451	0.000603	CcSEcCtD
Hydrochlorothiazide—Alopecia—Epirubicin—urinary bladder cancer	0.000447	0.000598	CcSEcCtD
Hydrochlorothiazide—Nausea—Gemcitabine—urinary bladder cancer	0.000446	0.000596	CcSEcCtD
Hydrochlorothiazide—Vomiting—Cisplatin—urinary bladder cancer	0.000445	0.000595	CcSEcCtD
Hydrochlorothiazide—Vision blurred—Methotrexate—urinary bladder cancer	0.000444	0.000593	CcSEcCtD
Hydrochlorothiazide—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000443	0.000592	CcSEcCtD
Hydrochlorothiazide—Rash—Cisplatin—urinary bladder cancer	0.000442	0.00059	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Cisplatin—urinary bladder cancer	0.000441	0.000589	CcSEcCtD
Hydrochlorothiazide—Erythema—Epirubicin—urinary bladder cancer	0.000441	0.000589	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Etoposide—urinary bladder cancer	0.000439	0.000586	CcSEcCtD
Hydrochlorothiazide—Nausea—Fluorouracil—urinary bladder cancer	0.000439	0.000586	CcSEcCtD
Hydrochlorothiazide—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000437	0.000584	CcSEcCtD
Hydrochlorothiazide—Tinnitus—Doxorubicin—urinary bladder cancer	0.000437	0.000583	CcSEcCtD
Hydrochlorothiazide—Anaemia—Methotrexate—urinary bladder cancer	0.000435	0.000581	CcSEcCtD
Hydrochlorothiazide—Flushing—Doxorubicin—urinary bladder cancer	0.000435	0.000581	CcSEcCtD
Hydrochlorothiazide—Flatulence—Epirubicin—urinary bladder cancer	0.000434	0.00058	CcSEcCtD
Hydrochlorothiazide—Tension—Epirubicin—urinary bladder cancer	0.000432	0.000578	CcSEcCtD
Hydrochlorothiazide—Dysgeusia—Epirubicin—urinary bladder cancer	0.000432	0.000576	CcSEcCtD
Hydrochlorothiazide—Nervousness—Epirubicin—urinary bladder cancer	0.000428	0.000572	CcSEcCtD
Hydrochlorothiazide—Back pain—Epirubicin—urinary bladder cancer	0.000426	0.000569	CcSEcCtD
Hydrochlorothiazide—Malaise—Methotrexate—urinary bladder cancer	0.000425	0.000567	CcSEcCtD
Hydrochlorothiazide—Dizziness—Etoposide—urinary bladder cancer	0.000424	0.000567	CcSEcCtD
Hydrochlorothiazide—Muscle spasms—Epirubicin—urinary bladder cancer	0.000424	0.000566	CcSEcCtD
Hydrochlorothiazide—Vertigo—Methotrexate—urinary bladder cancer	0.000423	0.000565	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Methotrexate—urinary bladder cancer	0.000421	0.000563	CcSEcCtD
Hydrochlorothiazide—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000418	0.000559	CcSEcCtD
Hydrochlorothiazide—Nausea—Cisplatin—urinary bladder cancer	0.000416	0.000556	CcSEcCtD
Hydrochlorothiazide—Vision blurred—Epirubicin—urinary bladder cancer	0.000415	0.000555	CcSEcCtD
Hydrochlorothiazide—Alopecia—Doxorubicin—urinary bladder cancer	0.000414	0.000553	CcSEcCtD
Hydrochlorothiazide—Cough—Methotrexate—urinary bladder cancer	0.000411	0.000549	CcSEcCtD
Hydrochlorothiazide—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000409	0.000546	CcSEcCtD
Hydrochlorothiazide—Vomiting—Etoposide—urinary bladder cancer	0.000408	0.000545	CcSEcCtD
Hydrochlorothiazide—Erythema—Doxorubicin—urinary bladder cancer	0.000408	0.000545	CcSEcCtD
Hydrochlorothiazide—Anaemia—Epirubicin—urinary bladder cancer	0.000407	0.000544	CcSEcCtD
Hydrochlorothiazide—Agitation—Epirubicin—urinary bladder cancer	0.000405	0.000541	CcSEcCtD
Hydrochlorothiazide—Rash—Etoposide—urinary bladder cancer	0.000405	0.00054	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Etoposide—urinary bladder cancer	0.000404	0.00054	CcSEcCtD
Hydrochlorothiazide—Headache—Etoposide—urinary bladder cancer	0.000402	0.000537	CcSEcCtD
Hydrochlorothiazide—Flatulence—Doxorubicin—urinary bladder cancer	0.000402	0.000537	CcSEcCtD
Hydrochlorothiazide—Chest pain—Methotrexate—urinary bladder cancer	0.000401	0.000536	CcSEcCtD
Hydrochlorothiazide—Arthralgia—Methotrexate—urinary bladder cancer	0.000401	0.000536	CcSEcCtD
Hydrochlorothiazide—Myalgia—Methotrexate—urinary bladder cancer	0.000401	0.000536	CcSEcCtD
Hydrochlorothiazide—Tension—Doxorubicin—urinary bladder cancer	0.0004	0.000534	CcSEcCtD
Hydrochlorothiazide—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000399	0.000533	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	0.000398	0.007	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—TYMS—urinary bladder cancer	0.000398	0.00698	CbGpPWpGaD
Hydrochlorothiazide—Malaise—Epirubicin—urinary bladder cancer	0.000397	0.000531	CcSEcCtD
Hydrochlorothiazide—Discomfort—Methotrexate—urinary bladder cancer	0.000396	0.000529	CcSEcCtD
Hydrochlorothiazide—Nervousness—Doxorubicin—urinary bladder cancer	0.000396	0.000529	CcSEcCtD
Hydrochlorothiazide—Vertigo—Epirubicin—urinary bladder cancer	0.000396	0.000529	CcSEcCtD
Hydrochlorothiazide—Syncope—Epirubicin—urinary bladder cancer	0.000395	0.000528	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Epirubicin—urinary bladder cancer	0.000394	0.000527	CcSEcCtD
Hydrochlorothiazide—Back pain—Doxorubicin—urinary bladder cancer	0.000394	0.000527	CcSEcCtD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—NCOR1—urinary bladder cancer	0.000393	0.0069	CbGpPWpGaD
Hydrochlorothiazide—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000392	0.000524	CcSEcCtD
Hydrochlorothiazide—Palpitations—Epirubicin—urinary bladder cancer	0.000389	0.00052	CcSEcCtD
Hydrochlorothiazide—Confusional state—Methotrexate—urinary bladder cancer	0.000387	0.000518	CcSEcCtD
Hydrochlorothiazide—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000387	0.000517	CcSEcCtD
Hydrochlorothiazide—Cough—Epirubicin—urinary bladder cancer	0.000385	0.000514	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000384	0.000513	CcSEcCtD
Hydrochlorothiazide—Vision blurred—Doxorubicin—urinary bladder cancer	0.000384	0.000513	CcSEcCtD
Hydrochlorothiazide—Nausea—Etoposide—urinary bladder cancer	0.000381	0.000509	CcSEcCtD
Hydrochlorothiazide—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000378	0.000505	CcSEcCtD
Hydrochlorothiazide—Anaemia—Doxorubicin—urinary bladder cancer	0.000377	0.000503	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000376	0.000503	CcSEcCtD
Hydrochlorothiazide—Arthralgia—Epirubicin—urinary bladder cancer	0.000375	0.000501	CcSEcCtD
Hydrochlorothiazide—Myalgia—Epirubicin—urinary bladder cancer	0.000375	0.000501	CcSEcCtD
Hydrochlorothiazide—Chest pain—Epirubicin—urinary bladder cancer	0.000375	0.000501	CcSEcCtD
Hydrochlorothiazide—Agitation—Doxorubicin—urinary bladder cancer	0.000375	0.000501	CcSEcCtD
Hydrochlorothiazide—Anxiety—Epirubicin—urinary bladder cancer	0.000374	0.000499	CcSEcCtD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000373	0.00656	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—PTGS2—urinary bladder cancer	0.000372	0.00654	CbGpPWpGaD
Hydrochlorothiazide—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000372	0.000496	CcSEcCtD
Hydrochlorothiazide—Discomfort—Epirubicin—urinary bladder cancer	0.000371	0.000495	CcSEcCtD
Hydrochlorothiazide—Malaise—Doxorubicin—urinary bladder cancer	0.000368	0.000491	CcSEcCtD
Hydrochlorothiazide—Dry mouth—Epirubicin—urinary bladder cancer	0.000367	0.00049	CcSEcCtD
Hydrochlorothiazide—Vertigo—Doxorubicin—urinary bladder cancer	0.000366	0.000489	CcSEcCtD
Hydrochlorothiazide—Anorexia—Methotrexate—urinary bladder cancer	0.000366	0.000489	CcSEcCtD
Hydrochlorothiazide—Syncope—Doxorubicin—urinary bladder cancer	0.000366	0.000488	CcSEcCtD
Hydrochlorothiazide—CA5B—Metabolism—GSTZ1—urinary bladder cancer	0.000366	0.00642	CbGpPWpGaD
Hydrochlorothiazide—Leukopenia—Doxorubicin—urinary bladder cancer	0.000365	0.000488	CcSEcCtD
Hydrochlorothiazide—Confusional state—Epirubicin—urinary bladder cancer	0.000363	0.000484	CcSEcCtD
Hydrochlorothiazide—Palpitations—Doxorubicin—urinary bladder cancer	0.00036	0.000481	CcSEcCtD
Hydrochlorothiazide—Oedema—Epirubicin—urinary bladder cancer	0.00036	0.00048	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00036	0.00048	CcSEcCtD
Hydrochlorothiazide—Hypotension—Methotrexate—urinary bladder cancer	0.000359	0.00048	CcSEcCtD
Hydrochlorothiazide—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000358	0.000479	CcSEcCtD
Hydrochlorothiazide—CA9—Cellular responses to stress—RBX1—urinary bladder cancer	0.000357	0.00626	CbGpPWpGaD
Hydrochlorothiazide—Cough—Doxorubicin—urinary bladder cancer	0.000356	0.000475	CcSEcCtD
Hydrochlorothiazide—Shock—Epirubicin—urinary bladder cancer	0.000354	0.000473	CcSEcCtD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—FAS—urinary bladder cancer	0.000352	0.00619	CbGpPWpGaD
Hydrochlorothiazide—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000352	0.00047	CcSEcCtD
Hydrochlorothiazide—Tachycardia—Epirubicin—urinary bladder cancer	0.000351	0.000469	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00035	0.000468	CcSEcCtD
Hydrochlorothiazide—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000348	0.000464	CcSEcCtD
Hydrochlorothiazide—Insomnia—Methotrexate—urinary bladder cancer	0.000348	0.000464	CcSEcCtD
Hydrochlorothiazide—Arthralgia—Doxorubicin—urinary bladder cancer	0.000347	0.000464	CcSEcCtD
Hydrochlorothiazide—Chest pain—Doxorubicin—urinary bladder cancer	0.000347	0.000464	CcSEcCtD
Hydrochlorothiazide—Myalgia—Doxorubicin—urinary bladder cancer	0.000347	0.000464	CcSEcCtD
Hydrochlorothiazide—CA5B—Metabolism—GSTO2—urinary bladder cancer	0.000347	0.00609	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—NAT1—urinary bladder cancer	0.000347	0.00609	CbGpPWpGaD
Hydrochlorothiazide—Anxiety—Doxorubicin—urinary bladder cancer	0.000346	0.000462	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Methotrexate—urinary bladder cancer	0.000345	0.000461	CcSEcCtD
Hydrochlorothiazide—Discomfort—Doxorubicin—urinary bladder cancer	0.000343	0.000458	CcSEcCtD
Hydrochlorothiazide—Anorexia—Epirubicin—urinary bladder cancer	0.000343	0.000458	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Methotrexate—urinary bladder cancer	0.000343	0.000458	CcSEcCtD
Hydrochlorothiazide—Somnolence—Methotrexate—urinary bladder cancer	0.000342	0.000456	CcSEcCtD
Hydrochlorothiazide—Dry mouth—Doxorubicin—urinary bladder cancer	0.000339	0.000454	CcSEcCtD
Hydrochlorothiazide—CA12—Metabolism—GSTZ1—urinary bladder cancer	0.000339	0.00595	CbGpPWpGaD
Hydrochlorothiazide—Dyspepsia—Methotrexate—urinary bladder cancer	0.000338	0.000452	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—CCND1—urinary bladder cancer	0.000337	0.00591	CbGpPWpGaD
Hydrochlorothiazide—Hypotension—Epirubicin—urinary bladder cancer	0.000336	0.000449	CcSEcCtD
Hydrochlorothiazide—Confusional state—Doxorubicin—urinary bladder cancer	0.000336	0.000448	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Methotrexate—urinary bladder cancer	0.000334	0.000446	CcSEcCtD
Hydrochlorothiazide—Oedema—Doxorubicin—urinary bladder cancer	0.000333	0.000445	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000333	0.000445	CcSEcCtD
Hydrochlorothiazide—Fatigue—Methotrexate—urinary bladder cancer	0.000331	0.000443	CcSEcCtD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	0.00033	0.0058	CbGpPWpGaD
Hydrochlorothiazide—Pain—Methotrexate—urinary bladder cancer	0.000329	0.000439	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000328	0.000438	CcSEcCtD
Hydrochlorothiazide—Shock—Doxorubicin—urinary bladder cancer	0.000327	0.000437	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000326	0.000435	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	0.000326	0.00572	CbGpPWpGaD
Hydrochlorothiazide—Insomnia—Epirubicin—urinary bladder cancer	0.000325	0.000435	CcSEcCtD
Hydrochlorothiazide—Tachycardia—Doxorubicin—urinary bladder cancer	0.000325	0.000434	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Epirubicin—urinary bladder cancer	0.000323	0.000431	CcSEcCtD
Hydrochlorothiazide—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000322	0.00043	CcSEcCtD
Hydrochlorothiazide—CA12—Metabolism—GSTO2—urinary bladder cancer	0.000321	0.00564	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—NAT1—urinary bladder cancer	0.000321	0.00564	CbGpPWpGaD
Hydrochlorothiazide—Dyspnoea—Epirubicin—urinary bladder cancer	0.000321	0.000428	CcSEcCtD
Hydrochlorothiazide—Somnolence—Epirubicin—urinary bladder cancer	0.00032	0.000427	CcSEcCtD
Hydrochlorothiazide—Anorexia—Doxorubicin—urinary bladder cancer	0.000317	0.000424	CcSEcCtD
Hydrochlorothiazide—CA5B—Metabolism—UGT2B7—urinary bladder cancer	0.000317	0.00557	CbGpPWpGaD
Hydrochlorothiazide—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000317	0.000423	CcSEcCtD
Hydrochlorothiazide—Dyspepsia—Epirubicin—urinary bladder cancer	0.000317	0.000423	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000314	0.00042	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Epirubicin—urinary bladder cancer	0.000313	0.000418	CcSEcCtD
Hydrochlorothiazide—Hypotension—Doxorubicin—urinary bladder cancer	0.000311	0.000415	CcSEcCtD
Hydrochlorothiazide—Fatigue—Epirubicin—urinary bladder cancer	0.00031	0.000414	CcSEcCtD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—CDK4—urinary bladder cancer	0.00031	0.00545	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—EP300—urinary bladder cancer	0.00031	0.00544	CbGpPWpGaD
Hydrochlorothiazide—Constipation—Epirubicin—urinary bladder cancer	0.000308	0.000411	CcSEcCtD
Hydrochlorothiazide—Pain—Epirubicin—urinary bladder cancer	0.000308	0.000411	CcSEcCtD
Hydrochlorothiazide—Urticaria—Methotrexate—urinary bladder cancer	0.000305	0.000408	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Methotrexate—urinary bladder cancer	0.000304	0.000406	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Methotrexate—urinary bladder cancer	0.000304	0.000406	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000303	0.000405	CcSEcCtD
Hydrochlorothiazide—Insomnia—Doxorubicin—urinary bladder cancer	0.000301	0.000402	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000299	0.000399	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000297	0.000396	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000296	0.000396	CcSEcCtD
Hydrochlorothiazide—Somnolence—Doxorubicin—urinary bladder cancer	0.000296	0.000395	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000294	0.000393	CcSEcCtD
Hydrochlorothiazide—CA12—Metabolism—UGT2B7—urinary bladder cancer	0.000294	0.00516	CbGpPWpGaD
Hydrochlorothiazide—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000293	0.000391	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000289	0.000386	CcSEcCtD
Hydrochlorothiazide—Fatigue—Doxorubicin—urinary bladder cancer	0.000287	0.000383	CcSEcCtD
Hydrochlorothiazide—Urticaria—Epirubicin—urinary bladder cancer	0.000286	0.000382	CcSEcCtD
Hydrochlorothiazide—CA5B—Metabolism—CYP4B1—urinary bladder cancer	0.000285	0.00501	CbGpPWpGaD
Hydrochlorothiazide—Constipation—Doxorubicin—urinary bladder cancer	0.000285	0.00038	CcSEcCtD
Hydrochlorothiazide—Pain—Doxorubicin—urinary bladder cancer	0.000285	0.00038	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Epirubicin—urinary bladder cancer	0.000284	0.00038	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Epirubicin—urinary bladder cancer	0.000284	0.00038	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000283	0.000378	CcSEcCtD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—PPARG—urinary bladder cancer	0.000282	0.00495	CbGpPWpGaD
Hydrochlorothiazide—Asthenia—Methotrexate—urinary bladder cancer	0.000276	0.000368	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000274	0.000366	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000272	0.000364	CcSEcCtD
Hydrochlorothiazide—Pruritus—Methotrexate—urinary bladder cancer	0.000272	0.000363	CcSEcCtD
Hydrochlorothiazide—CA4—Metabolism—GSTZ1—urinary bladder cancer	0.00027	0.00474	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—MYC—urinary bladder cancer	0.00027	0.00474	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—SLC19A1—urinary bladder cancer	0.000269	0.00473	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000265	0.00465	CbGpPWpGaD
Hydrochlorothiazide—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000265	0.000354	CcSEcCtD
Hydrochlorothiazide—CA12—Metabolism—CYP4B1—urinary bladder cancer	0.000264	0.00464	CbGpPWpGaD
Hydrochlorothiazide—Urticaria—Doxorubicin—urinary bladder cancer	0.000264	0.000353	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000263	0.000351	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000263	0.000351	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Methotrexate—urinary bladder cancer	0.000263	0.000351	CcSEcCtD
Hydrochlorothiazide—CA5B—Metabolism—PRSS3—urinary bladder cancer	0.000263	0.00461	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GSTZ1—urinary bladder cancer	0.000259	0.00455	CbGpPWpGaD
Hydrochlorothiazide—Asthenia—Epirubicin—urinary bladder cancer	0.000258	0.000345	CcSEcCtD
Hydrochlorothiazide—CA4—Metabolism—GSTO2—urinary bladder cancer	0.000256	0.0045	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—NAT1—urinary bladder cancer	0.000256	0.0045	CbGpPWpGaD
Hydrochlorothiazide—Pruritus—Epirubicin—urinary bladder cancer	0.000254	0.00034	CcSEcCtD
Hydrochlorothiazide—Dizziness—Methotrexate—urinary bladder cancer	0.000254	0.000339	CcSEcCtD
Hydrochlorothiazide—CA9—Cellular responses to stress—GSTP1—urinary bladder cancer	0.000253	0.00444	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000252	0.00443	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—SLC19A1—urinary bladder cancer	0.00025	0.00439	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—KRAS—urinary bladder cancer	0.000249	0.00438	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GSTZ1—urinary bladder cancer	0.000248	0.00436	CbGpPWpGaD
Hydrochlorothiazide—Diarrhoea—Epirubicin—urinary bladder cancer	0.000246	0.000329	CcSEcCtD
Hydrochlorothiazide—CA2—Metabolism—GSTO2—urinary bladder cancer	0.000245	0.00431	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—NAT1—urinary bladder cancer	0.000245	0.00431	CbGpPWpGaD
Hydrochlorothiazide—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000245	0.000328	CcSEcCtD
Hydrochlorothiazide—Vomiting—Methotrexate—urinary bladder cancer	0.000244	0.000326	CcSEcCtD
Hydrochlorothiazide—CA12—Metabolism—PRSS3—urinary bladder cancer	0.000243	0.00427	CbGpPWpGaD
Hydrochlorothiazide—Rash—Methotrexate—urinary bladder cancer	0.000242	0.000324	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Methotrexate—urinary bladder cancer	0.000242	0.000323	CcSEcCtD
Hydrochlorothiazide—Headache—Methotrexate—urinary bladder cancer	0.000241	0.000322	CcSEcCtD
Hydrochlorothiazide—CA9—Cellular responses to stress—CCNE1—urinary bladder cancer	0.000239	0.0042	CbGpPWpGaD
Hydrochlorothiazide—Asthenia—Doxorubicin—urinary bladder cancer	0.000239	0.000319	CcSEcCtD
Hydrochlorothiazide—Dizziness—Epirubicin—urinary bladder cancer	0.000238	0.000318	CcSEcCtD
Hydrochlorothiazide—Pruritus—Doxorubicin—urinary bladder cancer	0.000235	0.000315	CcSEcCtD
Hydrochlorothiazide—CA1—Metabolism—GSTO2—urinary bladder cancer	0.000235	0.00413	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—NAT1—urinary bladder cancer	0.000235	0.00413	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—UGT2B7—urinary bladder cancer	0.000234	0.00411	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—SOD2—urinary bladder cancer	0.000233	0.0041	CbGpPWpGaD
Hydrochlorothiazide—Vomiting—Epirubicin—urinary bladder cancer	0.000229	0.000305	CcSEcCtD
Hydrochlorothiazide—Nausea—Methotrexate—urinary bladder cancer	0.000228	0.000305	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000228	0.000304	CcSEcCtD
Hydrochlorothiazide—Rash—Epirubicin—urinary bladder cancer	0.000227	0.000303	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Epirubicin—urinary bladder cancer	0.000227	0.000303	CcSEcCtD
Hydrochlorothiazide—Headache—Epirubicin—urinary bladder cancer	0.000225	0.000301	CcSEcCtD
Hydrochlorothiazide—CA2—Metabolism—UGT2B7—urinary bladder cancer	0.000224	0.00394	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—GPX1—urinary bladder cancer	0.000223	0.00391	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—IFNA2—urinary bladder cancer	0.000221	0.00388	CbGpPWpGaD
Hydrochlorothiazide—Dizziness—Doxorubicin—urinary bladder cancer	0.00022	0.000294	CcSEcCtD
Hydrochlorothiazide—CA9—Metabolism—GSTZ1—urinary bladder cancer	0.000218	0.00383	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—UGT2B7—urinary bladder cancer	0.000215	0.00378	CbGpPWpGaD
Hydrochlorothiazide—Nausea—Epirubicin—urinary bladder cancer	0.000214	0.000285	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—HRAS—urinary bladder cancer	0.000212	0.00372	CbGpPWpGaD
Hydrochlorothiazide—Vomiting—Doxorubicin—urinary bladder cancer	0.000212	0.000283	CcSEcCtD
Hydrochlorothiazide—CA4—Metabolism—CYP4B1—urinary bladder cancer	0.000211	0.0037	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—TYMP—urinary bladder cancer	0.00021	0.00369	CbGpPWpGaD
Hydrochlorothiazide—Rash—Doxorubicin—urinary bladder cancer	0.00021	0.00028	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Doxorubicin—urinary bladder cancer	0.00021	0.00028	CcSEcCtD
Hydrochlorothiazide—Headache—Doxorubicin—urinary bladder cancer	0.000208	0.000278	CcSEcCtD
Hydrochlorothiazide—CA9—Metabolism—NAT1—urinary bladder cancer	0.000207	0.00363	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GSTO2—urinary bladder cancer	0.000207	0.00363	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—CYP4B1—urinary bladder cancer	0.000202	0.00355	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—SLC19A1—urinary bladder cancer	0.000199	0.0035	CbGpPWpGaD
Hydrochlorothiazide—Nausea—Doxorubicin—urinary bladder cancer	0.000198	0.000264	CcSEcCtD
Hydrochlorothiazide—CA12—Metabolism—TYMP—urinary bladder cancer	0.000195	0.00342	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PRSS3—urinary bladder cancer	0.000194	0.00341	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—CYP4B1—urinary bladder cancer	0.000194	0.0034	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—PTEN—urinary bladder cancer	0.000193	0.00339	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000192	0.00337	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—SLC19A1—urinary bladder cancer	0.000191	0.00335	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—NAT2—urinary bladder cancer	0.00019	0.00334	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—UGT2B7—urinary bladder cancer	0.000189	0.00332	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PRSS3—urinary bladder cancer	0.000186	0.00327	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—EP300—urinary bladder cancer	0.000184	0.00324	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—ATM—urinary bladder cancer	0.000184	0.00323	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—CDK4—urinary bladder cancer	0.000183	0.00322	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—SLC19A1—urinary bladder cancer	0.000183	0.00321	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PRSS3—urinary bladder cancer	0.000178	0.00313	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—NAT2—urinary bladder cancer	0.000176	0.00309	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—CYP4B1—urinary bladder cancer	0.00017	0.00299	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—RRM2—urinary bladder cancer	0.000164	0.00288	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—SLC19A1—urinary bladder cancer	0.000161	0.00283	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—CREBBP—urinary bladder cancer	0.00016	0.00281	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—RB1—urinary bladder cancer	0.000159	0.0028	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PRSS3—urinary bladder cancer	0.000157	0.00275	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—PLAU—urinary bladder cancer	0.000157	0.00275	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000156	0.00274	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—TYMP—urinary bladder cancer	0.000155	0.00272	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—RRM2—urinary bladder cancer	0.000152	0.00267	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—HPGDS—urinary bladder cancer	0.000152	0.00267	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—ENO2—urinary bladder cancer	0.000152	0.00267	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—TYMP—urinary bladder cancer	0.000149	0.00261	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—GSTT1—urinary bladder cancer	0.000147	0.00259	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—TYMP—urinary bladder cancer	0.000143	0.0025	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—ENO2—urinary bladder cancer	0.000141	0.00247	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—HPGDS—urinary bladder cancer	0.000141	0.00247	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—NAT2—urinary bladder cancer	0.00014	0.00246	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—CDKN2A—urinary bladder cancer	0.00014	0.00246	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—GSTT1—urinary bladder cancer	0.000136	0.0024	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—NAT2—urinary bladder cancer	0.000134	0.00236	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—TP53—urinary bladder cancer	0.000132	0.00232	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—CREBBP—urinary bladder cancer	0.000129	0.00227	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—NAT2—urinary bladder cancer	0.000129	0.00226	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—IGF1—urinary bladder cancer	0.000128	0.00224	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—CXCL8—urinary bladder cancer	0.000127	0.00223	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—TYMP—urinary bladder cancer	0.000125	0.0022	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—NQO1—urinary bladder cancer	0.000122	0.00215	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—RRM2—urinary bladder cancer	0.000121	0.00213	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000118	0.00207	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—RHOA—urinary bladder cancer	0.000117	0.00205	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—RRM2—urinary bladder cancer	0.000116	0.00204	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—CDKN1A—urinary bladder cancer	0.000114	0.00201	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—NAT2—urinary bladder cancer	0.000113	0.00199	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—NQO1—urinary bladder cancer	0.000113	0.00199	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—HPGDS—urinary bladder cancer	0.000112	0.00197	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—ENO2—urinary bladder cancer	0.000112	0.00197	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—RRM2—urinary bladder cancer	0.000111	0.00196	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—EP300—urinary bladder cancer	0.000109	0.00191	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—GSTT1—urinary bladder cancer	0.000109	0.00191	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—HPGDS—urinary bladder cancer	0.000108	0.00189	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—ENO2—urinary bladder cancer	0.000108	0.00189	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000105	0.00185	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GSTT1—urinary bladder cancer	0.000104	0.00183	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—ENO2—urinary bladder cancer	0.000103	0.00181	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—HPGDS—urinary bladder cancer	0.000103	0.00181	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—GSTP1—urinary bladder cancer	0.000102	0.00179	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GSTT1—urinary bladder cancer	0.0001	0.00176	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—IL2—urinary bladder cancer	9.81e-05	0.00172	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—RRM2—urinary bladder cancer	9.78e-05	0.00172	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Neuronal System—HRAS—urinary bladder cancer	9.7e-05	0.0017	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—TYMS—urinary bladder cancer	9.49e-05	0.00167	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—GSTP1—urinary bladder cancer	9.45e-05	0.00166	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—GSTM1—urinary bladder cancer	9.38e-05	0.00165	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—NCOR1—urinary bladder cancer	9.38e-05	0.00165	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—HPGDS—urinary bladder cancer	9.06e-05	0.00159	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—ENO2—urinary bladder cancer	9.06e-05	0.00159	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—NQO1—urinary bladder cancer	9.04e-05	0.00159	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—GPX1—urinary bladder cancer	8.98e-05	0.00158	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—ERCC2—urinary bladder cancer	8.82e-05	0.00155	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—EP300—urinary bladder cancer	8.8e-05	0.00155	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GSTT1—urinary bladder cancer	8.79e-05	0.00154	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—TYMS—urinary bladder cancer	8.79e-05	0.00154	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—NCOR1—urinary bladder cancer	8.69e-05	0.00153	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—GSTM1—urinary bladder cancer	8.69e-05	0.00153	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—NQO1—urinary bladder cancer	8.67e-05	0.00152	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—SRC—urinary bladder cancer	8.56e-05	0.0015	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—GPX1—urinary bladder cancer	8.32e-05	0.00146	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—NQO1—urinary bladder cancer	8.31e-05	0.00146	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—MTHFR—urinary bladder cancer	8.29e-05	0.00146	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—ERCC2—urinary bladder cancer	8.17e-05	0.00143	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—TP53—urinary bladder cancer	7.8e-05	0.00137	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—MTHFR—urinary bladder cancer	7.68e-05	0.00135	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—GSTP1—urinary bladder cancer	7.54e-05	0.00132	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—NQO1—urinary bladder cancer	7.3e-05	0.00128	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GSTP1—urinary bladder cancer	7.23e-05	0.00127	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—KRAS—urinary bladder cancer	7.09e-05	0.00125	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—TYMS—urinary bladder cancer	7.01e-05	0.00123	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GSTP1—urinary bladder cancer	6.93e-05	0.00122	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—GSTM1—urinary bladder cancer	6.93e-05	0.00122	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—NCOR1—urinary bladder cancer	6.93e-05	0.00122	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PPARG—urinary bladder cancer	6.72e-05	0.00118	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—TYMS—urinary bladder cancer	6.72e-05	0.00118	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—NCOR1—urinary bladder cancer	6.64e-05	0.00117	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GSTM1—urinary bladder cancer	6.64e-05	0.00117	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—GPX1—urinary bladder cancer	6.63e-05	0.00117	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—ERCC2—urinary bladder cancer	6.51e-05	0.00114	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—CREBBP—urinary bladder cancer	6.46e-05	0.00113	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—TYMS—urinary bladder cancer	6.44e-05	0.00113	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GSTM1—urinary bladder cancer	6.37e-05	0.00112	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—NCOR1—urinary bladder cancer	6.37e-05	0.00112	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GPX1—urinary bladder cancer	6.36e-05	0.00112	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—TP53—urinary bladder cancer	6.3e-05	0.00111	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—ERCC2—urinary bladder cancer	6.24e-05	0.0011	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PPARG—urinary bladder cancer	6.23e-05	0.00109	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—MTHFR—urinary bladder cancer	6.12e-05	0.00108	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GPX1—urinary bladder cancer	6.1e-05	0.00107	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GSTP1—urinary bladder cancer	6.09e-05	0.00107	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—HRAS—urinary bladder cancer	6.03e-05	0.00106	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—ERCC2—urinary bladder cancer	5.99e-05	0.00105	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—CREBBP—urinary bladder cancer	5.98e-05	0.00105	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—MTHFR—urinary bladder cancer	5.87e-05	0.00103	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—TYMS—urinary bladder cancer	5.66e-05	0.000995	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—MTHFR—urinary bladder cancer	5.63e-05	0.000989	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GSTM1—urinary bladder cancer	5.6e-05	0.000983	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—NCOR1—urinary bladder cancer	5.6e-05	0.000983	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GPX1—urinary bladder cancer	5.36e-05	0.000942	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PTGS2—urinary bladder cancer	5.29e-05	0.000929	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—ERCC2—urinary bladder cancer	5.26e-05	0.000925	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PPARG—urinary bladder cancer	4.96e-05	0.000872	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—MTHFR—urinary bladder cancer	4.95e-05	0.000869	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.94e-05	0.000867	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PTGS2—urinary bladder cancer	4.9e-05	0.00086	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—CREBBP—urinary bladder cancer	4.77e-05	0.000838	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PPARG—urinary bladder cancer	4.76e-05	0.000836	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PTEN—urinary bladder cancer	4.61e-05	0.00081	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—CREBBP—urinary bladder cancer	4.57e-05	0.000803	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PPARG—urinary bladder cancer	4.56e-05	0.000802	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—EP300—urinary bladder cancer	4.4e-05	0.000772	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—CREBBP—urinary bladder cancer	4.38e-05	0.00077	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PTEN—urinary bladder cancer	4.27e-05	0.00075	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—EP300—urinary bladder cancer	4.07e-05	0.000716	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PPARG—urinary bladder cancer	4.01e-05	0.000705	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PTGS2—urinary bladder cancer	3.91e-05	0.000686	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—CREBBP—urinary bladder cancer	3.85e-05	0.000677	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PTGS2—urinary bladder cancer	3.74e-05	0.000658	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PTGS2—urinary bladder cancer	3.59e-05	0.000631	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PTEN—urinary bladder cancer	3.41e-05	0.000598	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PTEN—urinary bladder cancer	3.27e-05	0.000574	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—EP300—urinary bladder cancer	3.25e-05	0.000571	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PTGS2—urinary bladder cancer	3.16e-05	0.000554	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PTEN—urinary bladder cancer	3.13e-05	0.00055	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—EP300—urinary bladder cancer	3.11e-05	0.000547	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—EP300—urinary bladder cancer	2.99e-05	0.000524	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PTEN—urinary bladder cancer	2.75e-05	0.000483	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—EP300—urinary bladder cancer	2.62e-05	0.000461	CbGpPWpGaD
